These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT. Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061 [TBL] [Abstract][Full Text] [Related]
24. Benefits of Wen G; Gu J; Zhou W; Wang L; Tian Y; Dong Y; Fu L; Wu H Eur Radiol; 2020 Sep; 30(9):5089-5098. PubMed ID: 32346795 [TBL] [Abstract][Full Text] [Related]
25. Textural features on 18F-FDG PET/CT and dynamic contrast-enhanced MR imaging for predicting treatment response and survival of patients with hypopharyngeal carcinoma. Wong CK; Chan SC; Ng SH; Hsieh CH; Cheng NM; Yen TC; Liao CT Medicine (Baltimore); 2019 Aug; 98(33):e16608. PubMed ID: 31415354 [TBL] [Abstract][Full Text] [Related]
26. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience. Hectors SJ; Wagner M; Besa C; Huang W; Taouli B Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045 [TBL] [Abstract][Full Text] [Related]
28. Update of the role of PET/CT and PET/MRI in the management of patients with cervical cancer. Khiewvan B; Torigian DA; Emamzadehfard S; Paydary K; Salavati A; Houshmand S; Shamchi SP; Werner TJ; Aydin A; Roy SG; Alavi A; Kumar R Hell J Nucl Med; 2016; 19(3):254-268. PubMed ID: 27824966 [TBL] [Abstract][Full Text] [Related]
29. Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study. Schoenmaekers J; Hofman P; Bootsma G; Westenend M; de Booij M; Schreurs W; Houben R; De Ruysscher D; Dingemans AM; Hendriks LEL Eur J Cancer; 2019 Jul; 115():88-96. PubMed ID: 31129385 [TBL] [Abstract][Full Text] [Related]
30. The complementary roles of dynamic contrast-enhanced MRI and 18F-fluorodeoxyglucose PET/CT for imaging of carotid atherosclerosis. Calcagno C; Ramachandran S; Izquierdo-Garcia D; Mani V; Millon A; Rosenbaum D; Tawakol A; Woodward M; Bucerius J; Moshier E; Godbold J; Kallend D; Farkouh ME; Fuster V; Rudd JH; Fayad ZA Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1884-93. PubMed ID: 23942908 [TBL] [Abstract][Full Text] [Related]
31. Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Schurink NW; Min LA; Berbee M; van Elmpt W; van Griethuysen JJM; Bakers FCH; Roberti S; van Kranen SR; Lahaye MJ; Maas M; Beets GL; Beets-Tan RGH; Lambregts DMJ Eur Radiol; 2020 May; 30(5):2945-2954. PubMed ID: 32034488 [TBL] [Abstract][Full Text] [Related]
32. Positron emission computed tomography and magnetic resonance imaging features of sinonasal small round blue cell tumors. Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z Neuroradiol J; 2020 Feb; 33(1):48-56. PubMed ID: 31460836 [TBL] [Abstract][Full Text] [Related]
33. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy. Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091 [TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513 [TBL] [Abstract][Full Text] [Related]